Publications, Patents and Examples
Strain development
Microbiome
Product Development
Functional Analyses
Regulatory
Clinical Trial
HUMIPLATE ® For Microbiome Modulation Properties Of A Plant Extract (Menthacarin).
-
Menthacarin, a proprietary combination of peppermint and caraway oil, alters cultured human fecal microbiota composition, resulting in increased SCFA production. Lehner MD, Ulsemer P and Christochowitz S (2025). Front. Pharmacol. 16:1569052. doi: 10.3389/fphar.2025.1569052
MicroSIS - Isolation And Further Development Of
Commensal Bacterial Strains Naturally Neutralizing The
-
Exploring the pathogen binding potential within the human gut microbiome.Human Microbiome Journal. Kawe Toutounian, Marie Luise Heinig, Peter Götz and Philippe Ulsemer. https://doi.org/10.1016/j.humic.2020.100075.
MicroSIS - Human Trial: Safety Of A Next Generation
-
Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults. Beneficial Microbes, 3(2), 99-112.. Ulsemer, P., Toutounian, K., Kressel, G., Schmidt, J., Karsten, U., Hahn, A., & Goletz, S. https://doi.org/10.3920/BM2011.0051
MicroSIS - Human Trial - Anti-Cancer Properties Of A
-
Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFα-specific antibodies in human adults. Beneficial Microbes, 7(4), 485-500.. Ulsemer, P., Toutounian, K., Kressel, G., Goletz, C., Schmidt, J., Karsten, U., Hahn, A., & Goletz, S. https://doi.org/10.3920/BM2015.0143
MicroSIS - Anti-Cancer Properties Of A Commensal
-
Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6. Cancer Immunol Immunother. May;62(5):875-87. Ulsemer P, Henderson G, Toutounian K, Löffler A, Schmidt J, Karsten U, Blaut M, Goletz S. doi: 10.1007/s00262-013-1394-x.
Regulatory: Safety Assessment Of A Next Generation
-
Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964. Regul Toxicol Pharmacol. Mar;62(2):336-46. Ulsemer P, Toutounian K, Schmidt J, Leuschner J, Karsten U, Goletz S. doi: 10.1016/j.yrtph.2011.10.014.
Regulatory: Safety Assessment Of A Next Generation
-
Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate. Appl Environ Microbiol. Ulsemer P, Toutounian K, Schmidt J, Karsten U, Goletz S. doi: 10.1128/AEM.06641-11.
MicroSIS - Isolation and further Development of Commesal
Bacteria Naturally Expressing Tumor Associated Carbohydrate
-
Occurrence of the human tumor-specific antigen structure Galβ1-3GalNAcα- (Thomsen-Friedenreich) and related structures on gut bacteria: prevalence, immunochemical analysis and structural confirmation. Glycobiology. (10):1277-89. Henderson G, Ulsemer P, Schöber U, Löffler A, Alpert CA, Zimmermann-Kordmann M, Reutter W, Karsten U, Goletz S, Blaut M. doi: 10.1093/glycob/cwr058.
Use of Commensal Bacteria As New Anti-Infection Agent
-
Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof. Applicant: ACARYON GMBH - Inventors: Philippe Ulsemer, Kawe Toutounian
Use of Commensal Bacteria As New Cancer Prevention
Agent
-
Microorganisms carrying a tumor antigen. Abstract: The present invention pertains to microorganisms of the species Bacteroides xylanisolvens expressing a core-1 antigen on their surface. These microorganisms are in particular useful for the prophylaxis and treatment of core-1 positive diseases.. Inventors: Steffen Goletz, Philippe Ulsemer, Kawe Toutounian
New Fermentation Process For Industrial Production of
Anaerobic Microorganism
-
Fermentation process:.Abstract: The present disclosure relates in one embodiment to a method of producing a fermented food .... Inventors: Steffen Goletz, Philippe Ulsemer
Carbohydrate Specific Cellular Immunity Inducing
Microorganisms And Fractions Thereof.
-
Abstract: The present invention relates to the field of prevention and treatment of disorders associated with the occurrence of certain carbohydrate epitopes. Inventors: Steffen Goletz, Philippe Ulsemer, Anja Löffler
Microorganisms Of The Species Bacteroides Xylanisolvens
-
The present invention pertains to food products comprising microorganisms of the species Bacteroides xylanisolvens. Inventors: Steffen Goletz, Philippe Ulsemer, Kawe Toutounian
Microorganisms or fractions thereof capable of
activating cellular immunity against carbohydrates.
-
Abstract: The present invention relates to the field of prevention and treatment of tumors and gastrointestinal disorders. Inventors: Steffen Goletz, Phillippe Ulsemer, Anja Löffler
